Trial intelligence / Profile preview

Silodosin for Male Contraception

NCT07195097Phase 1Not yet recruiting

Sponsor
Benha University
Start
Sep 2025
Primary completion
Nov 2025
Modality
Small Molecules
01

Overview

Phase 1, randomised trial in contraception comparing Silodosin arm with Placebo arm (2 arms). Primary endpoint: Pregnancy rate in people treated with sildosin as a male contraceptive at 3 months. Planned start Sep 2025; status: not yet recruiting.

02

Drugs

silodosin
03

Conditions

contraception

Beyond the preview

Go deeper on NCT07195097.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07195097.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call